Your browser doesn't support javascript.
loading
Drug utilization profile in adult patients with refractory epilepsy at a tertiary referral center / Perfil de utilizacao de farmacos por pacientes adultos com epilepsia refrataria em um centro terciario de referencia
Freitas-Lima, Priscila de; Baldoni, Andre de Oliveira; , Veriano; Pereira, Leonardo Regis Leira; Sakamoto, Americo Ceiki.
  • Freitas-Lima, Priscila de; University of Sao Paulo. Ribeirao Preto School of Medicine. Sao Paulo. BR
  • Baldoni, Andre de Oliveira; University of Sao Paulo. Ribeirao Preto School of Medicine. Sao Paulo. BR
  • , Veriano; University of Sao Paulo. Ribeirao Preto School of Medicine. Sao Paulo. BR
  • Pereira, Leonardo Regis Leira; University of Sao Paulo. Ribeirao Preto School of Medicine. Sao Paulo. BR
  • Sakamoto, Americo Ceiki; University of Sao Paulo. Ribeirao Preto School of Medicine. Sao Paulo. BR
Arq. neuropsiquiatr ; 71(11): 856-861, 1jan. 2013. tab, graf
Article in English | LILACS | ID: lil-691305
ABSTRACT
Objective To evaluate the utilization profile of antiepileptic drugs in a population of adult patients with refractory epilepsy attending a tertiary center. Method Descriptive analyses of data were obtained from the medical records of 112 patients. Other clinical and demographic characteristics were also registered. Results Polytherapies with ≥3 antiepileptic drugs were prescribed to 60.7% of patients. Of the old agents, carbamazepine and clobazam were the most commonly prescribed (72.3% and 58.9% of the patients, respectively). Among the new agents, lamotrigine was the most commonly prescribed (36.6% of the patients). At least one old agent was identified in 103 out of the 104 polytherapies, while at least one new agent was prescribed to 70.5% of the population. The most prevalent combination was carbamazepine + clobazam + lamotrigine. The mean AED load found was 3.3 (range 0.4–7.7). Conclusion The pattern of use of individual drugs, although consistent with current treatment guidelines, is strongly influenced by the public health system. .
RESUMO
Objetivo Avaliar o perfil de utilização de fármacos antiepilépticos em uma população de pacientes adultos com epilepsia refratária atendidos em um centro terciário. Método Análises descritivas dos dados obtidos dos registros médicos de 112 pacientes. Também foram consideradas as características clínicas e demográficas. Resultados Foram prescritas politerapias com ≥3 antiepilépticos a 60,7% dos pacientes. Em relação aos fármacos de primeira geração, carbamazepina e clobazam foram os mais frequentemente prescritos (a 72,3% e 58,9% dos pacientes, respectivamente). Dentre os novos antiepilépticos, a lamotrigina foi o mais prescrito (36,6% dos pacientes). Ao menos um antiepiléptico de primeira geração foi encontrado em 103 das 104 politerapias; ao menos um novo antiepiléptico foi prescrito a 70,5% da população. A combinação mais prevalente foi carbamazepina+clobazan+lamotrigina. A carga média de antiepilépticos foi 3.3 (0.4 a 7.7). Conclusão O padrão de utilização de antiepilépticos, embora concordante com guias atuais, é fortemente influenciado pelo sistema público de saúde. .
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Epilepsy / Tertiary Care Centers / Anticonvulsants Type of study: Practice guideline / Prognostic study Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arq. neuropsiquiatr Journal subject: Neurology / Psychiatry Year: 2013 Type: Article Affiliation country: Brazil Institution/Affiliation country: University of Sao Paulo/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Epilepsy / Tertiary Care Centers / Anticonvulsants Type of study: Practice guideline / Prognostic study Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arq. neuropsiquiatr Journal subject: Neurology / Psychiatry Year: 2013 Type: Article Affiliation country: Brazil Institution/Affiliation country: University of Sao Paulo/BR